Biomarkers in cervical cancer
Abstract
Cervical cancer, a potentially preventable disease, remains the second most common malignancy in women worldwide. Human papillomavirus (HPV) is the single most important etiological agent in cervical cancer, contributing to neoplastic progression through the action of viral oncoproteins, mainly E6 and E7. Cervical screening programs using Pap smear testing have dramatically improved cervical cancer incidence and reduced deaths, but cervical cancer still remains a global health burden. The biomarker discovery for accurate detection and diagnosis of cervical carcinoma and its malignant precursors (collectively referred to as high-grade cervical disease) represents one of the current challenges in clinical medicine and cytopathology.
Keywords: Cervical cancer; Human papillomavirus (HPV); biomarker.
Figures
Similar articles
-
Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.Mol Diagn Ther. 2007;11(5):277-90. doi: 10.1007/BF03256249. Mol Diagn Ther. 2007. PMID: 17963416 Review.
-
HPV and cervical cancer: updates on an established relationship.Postgrad Med. 2008 Nov;120(4):7-13. doi: 10.3810/pgm.2008.11.1928. Postgrad Med. 2008. PMID: 19020360 Review.
-
What next in cervical cancer screening?Ceska Gynekol. 2020 Winter;85(4):236-243. Ceska Gynekol. 2020. PMID: 33562978 Review. English.
-
Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.Cancer. 1998 Dec 1;83(11):2346-52. doi: 10.1002/(sici)1097-0142(19981201)83:11<2346::aid-cncr14>3.0.co;2-g. Cancer. 1998. PMID: 9840534
-
Comparison of the detection of HPV-16, 18, 31, 33, and 45 by type-specific DNA- and E6/E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears.J Virol Methods. 2013 Dec;194(1-2):222-8. doi: 10.1016/j.jviromet.2013.08.036. Epub 2013 Sep 13. J Virol Methods. 2013. PMID: 24036071
Cited by
-
Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review.Discov Oncol. 2022 Sep 24;13(1):91. doi: 10.1007/s12672-022-00551-9. Discov Oncol. 2022. PMID: 36152065 Free PMC article. Review.
-
Detection and pathological value of papillomavirus DNA and p16INK4A and p53 protein expression in cervical intraepithelial neoplasia.Oncol Lett. 2014 Mar;7(3):738-744. doi: 10.3892/ol.2014.1791. Epub 2014 Jan 14. Oncol Lett. 2014. PMID: 24527081 Free PMC article.
-
The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers.Cell Biol Toxicol. 2024 Jun 5;40(1):42. doi: 10.1007/s10565-024-09884-3. Cell Biol Toxicol. 2024. PMID: 38836981 Free PMC article. Review.
-
Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.Biomark Insights. 2007 Dec 11;2:447-61. Biomark Insights. 2007. PMID: 19662225 Free PMC article.
-
Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency.Genes (Basel). 2021 Jan 20;12(2):130. doi: 10.3390/genes12020130. Genes (Basel). 2021. PMID: 33498485 Free PMC article. Review.
References
-
- Al-Nafussi AI, Klys HS, Rebello G, et al. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in the uterine cervix and cervical squamous neoplasia. Int J Gynecol Cancer. 1993;3:154–8. - PubMed
-
- Antonsson A, Payne E, Hengst K, et al. The Human Papillomavirus Type 16 E7 Protein Binds Human Interferon Regulatory Factor-9 via a Novel PEST Domain Required for Transformation. J Interferon Cytokine Res. 2006;26:455–61. - PubMed
-
- Autier P, Coibion M, De Sutter P, et al. Cytology alone versus cytology and cervicography for cervical cancer screening: a randomized study. Obstet Gynecol. 1999;93:353–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials